News
Medtronic to spin off diabetes business, form new company
Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a standalone company. The new diabetes company will focus on accelerating innovation and addressing intensive insulin management, according to a news release from Fridley-based Medtronic.
Medtronic expects Trump administration tariffs and reciprocal tariffs from other countries to cost it $200–350 million over ...
Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...
Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...
The company has started to add bearish views on Wall Street as the healthcare giant's business practices draw public scrutiny, risking its prospects, worsened by its recent leadership change. Bank of ...
Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
Q4 results handily beat expectations, but the real story was its cautious FY26 outlook, which sent shares lower in early ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback